{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:08:15Z","timestamp":1784297295650,"version":"3.55.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/ijo.2017.3863","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T12:01:16Z","timestamp":1485432076000},"page":"1029-1034","source":"Crossref","is-referenced-by-count":12,"title":["PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells"],"prefix":"10.3892","volume":"50","author":[{"given":"Amany Sayed","family":"Mawas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwa Jeet","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouchira M.","family":"Mohi El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"key20180107175721_b1-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"716724A","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Delgermaa","year":"2011","journal-title":"Bull World Health Organ"},{"key":"key20180107175721_b2-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1183\/09031936.96.09091932","article-title":"The epidemiology of mesothelioma in historical context","volume":"9","author":"McDonald","year":"1996","journal-title":"Eur Respir J"},{"key":"key20180107175721_b3-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/ijo.2016.3358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Amatya","year":"2016","journal-title":"Int J Oncol"},{"key":"key20180107175721_b4-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35090585","article-title":"Delineation of prognostic biomarkers in prostate cancer","volume":"412","author":"Dhanasekaran","year":"2001","journal-title":"Nature"},{"key":"key20180107175721_b5-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cbt.7.9.6418","article-title":"Hypoxia-inducible protooncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma","volume":"7","author":"Reiser-Erkan","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key20180107175721_b6-ijo-50-03-1029","first-page":"4451","article-title":"Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer","volume":"29","author":"Warnecke-Eberz","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180107175721_b7-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/neuonc\/nou216","article-title":"Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival","volume":"17","author":"Herzog","year":"2015","journal-title":"Neuro Oncol"},{"key":"key20180107175721_b8-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2217\/fon.10.106","article-title":"Why target PIM1 for cancer diagnosis and treatment?","volume":"6","author":"Magnuson","year":"2010","journal-title":"Future Oncol"},{"key":"key20180107175721_b9-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Usami","year":"2006","journal-title":"Cancer Sci"},{"key":"key20180107175721_b10-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2144\/000112257","article-title":"CellProfiler: Free, versatile software for automated biological image analysis","volume":"42","author":"Lamprecht","year":"2007","journal-title":"Biotechniques"},{"key":"key20180107175721_b11-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2144\/000113083","article-title":"TScratch: A novel and simple software tool for automated analysis of monolayer wound healing assays","volume":"46","author":"Geb\u00e4ck","year":"2009","journal-title":"Biotechniques"},{"key":"key20180107175721_b12-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10147-015-0925-1","article-title":"Trimodality strategy for treating malignant pleural mesothelioma: Results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and post- operative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"key20180107175721_b13-ijo-50-03-1029","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000225","article-title":"Trimodality treatment of malignant pleural mesothelioma: An Institutional Review","author":"Kapeles","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"key20180107175721_b14-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107175721_b15-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: A population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107175721_b16-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.20820","article-title":"Predictions of mortality from pleural mesothelioma in Italy: A model based on asbestos consumption figures supports results from age-period- cohort models","volume":"115","author":"Marinaccio","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180107175721_b17-ijo-50-03-1029","first-page":"1369","article-title":"Overexpression of CD26\/DPPIV in mesothelioma tissue and mesothelioma cell lines","volume":"26","author":"Amatya","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107175721_b18-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-11-1990","article-title":"CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma","volume":"18","author":"Aoe","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107175721_b19-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","article-title":"Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors","volume":"13","author":"Inamoto","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107175721_b20-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/138955707780059853","article-title":"CD26\/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders","volume":"7","author":"Thompson","year":"2007","journal-title":"Mini Rev Med Chem"},{"key":"key20180107175721_b21-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12885-016-2718-y","article-title":"Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma","volume":"16","author":"Bickel","year":"2016","journal-title":"BMC Cancer"},{"key":"key20180107175721_b22-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00280-016-3010-1","article-title":"A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors","volume":"77","author":"Shimizu","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107175721_b23-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.jtho.2016.06.024","article-title":"A Phase II study of PF-03446962 in patients with advanced malignant pleural mesothelioma. CCTG Trial IND207","volume":"11","author":"Wheatley-Price","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key20180107175721_b24-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2217\/nnm.15.61","article-title":"Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents","volume":"10","author":"Zhao","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"key20180107175721_b25-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat Mater"},{"key":"key20180107175721_b26-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1756-9966-29-161","article-title":"Overexpression of Pim-1 in bladder cancer","volume":"29","author":"Guo","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107175721_b27-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1593\/neo.81038","article-title":"Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor","volume":"11","author":"Peltola","year":"2009","journal-title":"Neoplasia"},{"key":"key20180107175721_b28-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1172\/JCI26273","article-title":"The survival kinases Akt and Pim as potential pharmacological targets","volume":"115","author":"Amaravadi","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180107175721_b29-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/abbi.1996.0251","article-title":"Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1","volume":"330","author":"Liang","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"key20180107175721_b30-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-08-0634","article-title":"Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels","volume":"68","author":"Morishita","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107175721_b31-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/MPA.0b013e31823cdd10","article-title":"IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines","volume":"41","author":"Block","year":"2012","journal-title":"Pancreas"},{"key":"key20180107175721_b32-ijo-50-03-1029","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-014-0095-z","article-title":"Pim kinases in hematological malignancies: Where are we now and where are we going?","volume":"7","author":"Mondello","year":"2014","journal-title":"J Hematol Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2017.3863\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T20:51:16Z","timestamp":1658523076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2017.3863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,1,26]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/ijo.2017.3863"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2017.3863","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}